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Implications	 for	Nursing	Care
Zika	Virus
Abigail	Hanneken	RN,	BSN
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Additional	 Sources
Zika	virus	(ZIKV)	is	a	member	of	the	
Spondweni	serocomplex	within	the	
genus	Flavivovirus,	family	flaviviridae	
(Weaver	 et.	al,	2012).	ZIKV	is	related	to	
dengue,	West	Nile,	and	yellow	fever	
viruses	(Lazear et.	al,	2016).	ZIKV	was	
first	discovered	in	Uganda,	but	since	
then	outbreaks	have	been	reported	 in	
Africa	and	Southeast	Asia.
In	May	2015,	the	Pan	American	
Health	 Organization	(PAHO)	issued	an	
alert	 regarding	 the	first	confirmed	Zika	
virus	infection	in	Brazil,	where	it	began	
to	rapidly	spread	throughout	the	region	
(CDC,	2016).		Recently,	the	World	
Health	 Organization	(WHO)	declared	
the	ongoing	outbreak	of	Zika	virus	and	
associated	complications	in	the	
Americas,	the	Caribbean,	and	the	
Pacific	a	Public	Health	Emergency	of	
International	Concern	(Coyle,	2016,	p.	
22).		It	is	believed	that	the	Zika	virus	
will	likely	continue	to	spread	to	new	
areas	 (CDC,	2016).	
ZIKV	outbreak	is	very	concerning,	
due	to	the	fact	that	there	 currently	 is	
not	a	vaccine	or	antiviral	treatment	 and	
it	has	been	linked	to	fetal	mortality,	
Guillain-Barre	syndrome	(GBS),	and	
encephalopathy	(Johnson,	2016).	This	is	
also	a	growing	concern	since	many	
individuals	will	be	traveling	from	all	
over	 the	world	to	Brazil,	who	had	their	
first	case	of	ZIKV	last	May,	for	the	2016	
Summer	Olympics.	
The	purpose	of	this	subject	matter	
is	to	educate	and	spread	awareness	of	
the	disease	process	to	help	prevent	the	
disease	from	continuing	to	spread	
throughout	the	world.	
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Conclusion
Underlying	Pathophysiology
Significance	of	Pathophysiology
Advanced	 practice	 nurses	 (APNs)	 could	 vastly	 impact	
this	 issue	 by	 teaching	 the	population	 ways	 to	prevent	 the	
virus	 from	continuing	 to	spread	 to	new	 areas.	 Preventing	
the	disease	 from	 spreading	 can	be	achieved	 by	educating	
others.
Prevention:
Avoid	 mosquito	 bites	 – while	 traveling	 and	after	 returning	
for	3	weeks
• Wear	 insect	 repellent
• Wear	 long	 sleeved	 shirts	 and	pants	 &	spray	 with	
permethrin
• Sleep	 indoors
• Outdoors	 use	 mosquito	 bed	 net
• Avoid	 areas	 with	 standing	 water	 	 		
Sexually	 Responsibili ty
• Use	condoms	 for	8	weeks	 after	 traveling	 to	areas	with	
Zika	 to	mitigate	 possible	 sexual	 transmission,	 if	 the	
individual	 develops	 symptoms	 a	condom	 should	 be	
used	 for	6	months
• Abstinence	
(Coyle,	 2016)
APNs	 must	 educate	 the	population	 on	 the	 different	
modes	 of	 transmission.	 This	 is	 important	 because	 it	helps	
inhibit	 individuals	 and	mosquitos	 from	acquiring	 the	virus.	
This	 will	 prevent	 the	virus	 from	being	 spread	 to	new	areas	
and	 to	more	 individuals.
Modes	 of	Transmission:
• Aedes Mosquito	 species	 bites	 – Mosquitos	 can	
transmit	 to	humans	 and	 non-infected	 mosquitos	 can	
acquire	 virus	 from	 infected	 human
• Sexual	 contact
• Blood	 transfusion
• Crossing	 placental	 barrier
(Coyle,	 2016)
Another	 way	APNs	 can	help	 prevent	 Zika	 from	
continuing	 to	spread	 is	by	educating	 the	 population	 on	 the	
different	 symptoms	 that	are	associated	 with	 the	Zika	 virus.	
It	is	 important	 to	 recognize	 these	 symptoms	 and	contact	
your	 physician,	 where	 he/she	 may	 test	 urine	 or	blood	 for	
Zika.
Prevention	 is	 pivotal	 for	controlling	 the	spread	 of	Zika,	
due	 to	 the	 fact	that	 there	 is	 not	an	antiviral	 or	other	
specific	 treatment	 available	 to	 treat	 the	Zika	virus.	
However,	 APNs	 can	offer	 supportive	 care	 for	 symptom	
management	 	(CDC,2016).
Supportive	 Care:
• Rest
• Fluids
• Antipyretics
• Analgesics
(Coyle,	2016)
For	those	who	are	infected,	APNs	can	offer	
counseling	services	regarding,	fetal	mortality,	GBS,	and	
microcephaly
Signs	and	Symptoms
Low-grade	fever
Maculopapular	Rash
Conjunctivitis
Myalgia
Arthralgia
Headache
Malaise
(Weaver	et	al,	2016)
According	to	Coyle	(2016),	eighty	percent	
of	those	infected	with	Zika	virus	will	have	
no	symptoms,	and	those	who	are	
symptomatic	typically	show	signs	that	
include:
For	the	twenty	percent	that	do	exhibit	
these	symptoms,	it	is	important	to	know	
that	the	symptoms	typically	only	last	for	
two	to	seven	days.
Figure	3.	Protect	your	family	and	community:	How	
Zika	spreads.	By	Centers	for	Disease	Control	and	
Prevention,	2016
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Figure	1.	Sick	with	chikungunya,	dengue,	or	Zika?	 	
By	Centers	for	Disease	Control	and	Prevention,	
2016
Figure	2.	Zika	Virus	by	Navy	Marine	Corps	Public	Health	
Center	and	 the	Centers	for	Disease	Control	
Zika	virus	 is	an	arthropod-borne	virus	 (arbovirus);	arthropod	
vectors	include	mosquitoes,	 ticks,	and	 fleas.		Once	a	mosquito	 is	
infected	with	 the	virus,	 the	virus	 replicates	 in	 the	mosquito’s	 gut,	
and	passes	 the	virus	onto	a	human	with	 its	bite	 (Coyle,	2016,	
p.22).	Following	a	mosquito	 bite	 from	an	Aedes	 aegypti	or	Aedes	
albopictus,	 keratinocytes	and	dendritic	 cells	 in	 the	skin	are	
presumed	to	be	the	 initial	 targets	of	ZIKV	 infections.		 Studies	
have	also	showed	 that	the	phosphatidylserine	 receptor	AXL	can	
act	as	a	ZIKV	entry	receptor	and	for	cellular	autophagy	in	
enhancing	ZIKV	replication.	 	This	 replication	of	ZIKV	leads	 to	
activation	of	an	antiviral	 innate	 immune	response	and	
production	of	 type	1	interferons	 in	 infected	cells	 (Hamel	et. 	al,	
2015).	After	 the	initial	 bite	 ,	 viremia	develops	 1	to	5	days	later,	
and	 the	virus	 is	 thought	 to	be	cleared	within	 2	weeks.	ZIKV	has	a	
positive-sense,	 single	 stranded	RNA	genome	approximately	11	
kilobases	 in	 length.	The	genome	contains	5’	and	3’	untranslated	
regions	 flanking	a	single	 open	 reading	 from	(ORF)	that	encodes	a	
polyprotein	 that	is	 cleaved	into	 three	structural	proteins:	 the	
capsid	 (C),	premembrane/membrane	(prM),	and	envelope	 (E),	
and	seven	non-structural	proteins	 (Haddow	et	al,	2012).	
Although	 the	pathophysiology	 of	ZIKV	is	not	completely	understood,	 the	
complications	 that	can	arise	 from	the	virus	are	extremely	alarming.		
Recently,	ZIKV	has	been	linked	 to	fetal	 immortality,	 	microcephaly,	and	
Guillain-Barre	 syndrome.
Microcephaly:	
Decreased	occipitofrontal	 circumference
Abnormal	brain	development
Developmental	delay;	seizures;	 and	speech,	hearing,	and	
vision	 deficits
Infant	mortality
Fetal	loss	 in	 first	 trimester
Live	births	 with	 rapid	demise
Guillain-Barré	 syndrome	
Autoimmune	disease	 – attacks	peripheral	 nervous	system	–
triggered	by	virus
Progressive	 limb	weakness	and	often	 flaccid	paralysis
Can	be	reversible,	 lead	 to	 long-term	disability,	 or	mortality
(Johnson,	 2016)
The	Zika	virus	is	a	growing	concern	for	
the	world,	as	it	continues	to	spread.	The	
fact	that	it	is	now	linked	to	
microcephaly,	 fetal	immortality,	and	
Guillain-Barre	syndrome	is	worrisome.
Since	there	is	not	a	vaccine	or	antivirals	
available	for	the	Zika	virus,	education	
and		public	 awareness	are	vitally	
important	to	help	prevent	the	virus	from	
continuing	 	to	spread	throughout	the	
world.	
